share_log

4: Statement of changes in beneficial ownership of securities-Director Finizio Robert G

4: Statement of changes in beneficial ownership of securities-Director Finizio Robert G

4:持股变动声明-董事 Finizio Robert G
美股SEC公告 ·  07/19 09:36

Moomoo AI 已提取核心信息

In a recent transaction dated 05/24/2023, Robert G Finizio, associated with ZyVersa Therapeutics, Inc. [ZVSA], was reported to have engaged in a financial action with the company's stock. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the resulting number of shares held by Finizio after the action, were not disclosed in the announcement. The absence of this information leaves a gap in understanding the full impact of the transaction on Finizio's holdings and the company's stock.
In a recent transaction dated 05/24/2023, Robert G Finizio, associated with ZyVersa Therapeutics, Inc. [ZVSA], was reported to have engaged in a financial action with the company's stock. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the resulting number of shares held by Finizio after the action, were not disclosed in the announcement. The absence of this information leaves a gap in understanding the full impact of the transaction on Finizio's holdings and the company's stock.
最近有一笔日期为05/24/2023的交易,ZyVersa Therapeutics公司[ZVSA]的相关人员Robert G Finizio与该公司的股票进行了财务交易。交易的具体细节,包括所涉及的股票数量、股票的性质、交易价格以及Finizio在此次交易后持有的股票数量等,未在公告中公开。缺乏这些信息使我们难以完全理解此次交易对Finizio持有的股票以及公司的股票造成的影响。
最近有一笔日期为05/24/2023的交易,ZyVersa Therapeutics公司[ZVSA]的相关人员Robert G Finizio与该公司的股票进行了财务交易。交易的具体细节,包括所涉及的股票数量、股票的性质、交易价格以及Finizio在此次交易后持有的股票数量等,未在公告中公开。缺乏这些信息使我们难以完全理解此次交易对Finizio持有的股票以及公司的股票造成的影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息